#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Neuropathic arthropathy Activated PI3 kinase delta syndrome Gastroenteropancreatic neuroendocrine tumour disease Erythema Myotonia Trigeminal neuralgia Pseudoxanthoma elasticum Rhabdomyosarcoma Squamous cell carcinoma of the hypopharynx Autoimmune haemolytic anaemia Acquired haemophilia Chorioretinitis IgA nephropathy Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Diagnostics Wiskott-Aldrich syndrome – Treatment Mantle cell lymphoma refractory – Treatment Pemphigoid – Life with Disease Metachromatic leukodystrophy – Diagnostics Bronchopulmonary dysplasia Cystic fibrosis lung – Treatment Methylmalonic acidaemia – Diagnostics Glycogen storage disease type I – Trials in Disease Pulmonary sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Omp10 Gsk4527226 NIZUBAGLUSTAT Eftilagimod Alfa Efgartigimod Alfa T89 Ads-011 Linerixibat RO7288817 Alogliptin LUNSEKIMIG Trometamol Pemigatinib SEVABERTINIB Enalapril DESMOPRESSIN ACETATE Glenzocimab Perindopril Arginine Elacestrant Nicotinamide Bp More therapies…

    Learn about Your Condition

    Plasma cell myeloma refractory Paget's disease of the vulva Hypochondroplasia Krabbe's disease Inguinal hernia Incisional hernia Psychotic disorder Epidermolysis bullosa Mantle cell lymphoma Acute promyelocytic leukaemia Idiopathic pulmonary fibrosis Raynaud's phenomenon Shock Mucopolysaccharidosis Malignant glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effects of BMS-986470 for Patients with Sickle Cell Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • BMS-986470
    France Italy

  • Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    • Apremilast
    Belgium Bulgaria Croatia Czechia Estonia Germany +6

  • Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • ATUMELNANT
    Austria France Germany Italy The Netherlands Poland +1

  • Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Venetoclax
    • Obinutuzumab
    • Pirtobrutinib
    Austria Belgium Czechia Denmark Finland France +8

  • Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

    Recruiting

    3 1
    Investigated Drugs:
    • SELTOREXANT
    Bulgaria Czechia Italy Poland Portugal Romania +3

  • Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Prader-Willi syndrome
    Belgium Czechia Denmark France Germany Italy +4

  • Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    Belgium France Greece Italy The Netherlands Spain

  • Study on the Effects and Safety of Daratumumab, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Plasmablastic Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasmablastic lymphoma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Daratumumab
    • Bortezomib
    Italy
Previous Page
1 … 6 7 8 9 10 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!